石家庄鼎旻医药科技有限公司

石家庄鼎旻医药科技有限公司

河北省石家庄市翟营大街52号

2019

10至19

25,000,000至29,999,999

石家庄鼎旻医药科技有限公司成立于2014年10月，是一家专注于医药原料药和中间体的研发、生产、销售及提供技术服务的专业公司。公司研发方向主要专注于生产技术壁垒高、附加值高的医药原料药、医药中间体、农药中间体以及手性化合物等。主打产品是抗癌系列原料和心脑血管类原料及其中间体。公司目前在石家庄有两个工厂及一个研发中心（面积1000m2），并且有两家GMP合作工厂，配套有高效液相色谱仪、气相色谱仪、自动旋光仪、恒温恒湿箱等高端研发质控设备，及多功能原料药车间，能够满足客户不同质量的要求。公司坚持“诚信，专业，创新”的企业理念，以最优质的产品质量、最优惠的合理价格和最热情的服务来满足您的需求，创造我们的信誉，竭诚欢迎国内外朋友前来洽谈业务，交流指导，携手并进，共创辉煌。

239000

http://www.dingminpharmaceutical.com

制造商

中国,北美洲,中/南美洲,西欧,东欧,亚洲

测试产品1;测试产品2;测试产品3;测试产品4;测试产品5;测试产品6;测试产品7;测试产品8;测试产品9;测试产品10;3-Fluoro-4-Methylphenylisothiocyanate;N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine Methyl Ester;N-[3-Fluoro-4-[(Methylamino)Carbonyl]Phenyl]-2-Methylalanine;Apalutamide;5-Amino-3-(trifluromethyl) picolinonitrile;5-isothiocyanato-3-(trifluoromethyl)picolinonitrile;Ivacaftor (VX-770);4-oxo-1,4-dihydroquinoline-3-carboxylic acid;5-amino-2,4-di-tert-butylphenol hydrochloride;2,4-di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl methyl carbonate;Lumacaftor (VX-809);1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarbonitrile;1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxylic acid;6-chloro-5-methylpyridin-2-amine;3-(6-Amino-3-methyl-pyridin-2-yl)-benzoicacidtert-butylester;Tezacaftor (VX-661);2-bromo-5-fluoro-4-nitroaniline;(R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol;(((2,2-dimethylbut-3-yn-1-yl)oxy)methyl)benzene;2-[1-(benzyloxy)-2-methylpropan-2-yl]-6-fluoro-5-nitro-1H-indole;Lorlatinib;1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride;5'-Fluoro-2'-iodoacetophenone;(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol;methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate;Selexipag;2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid;4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol;5-Chloro-2,3-diphenylpyrazine;2-Bromo-5,6-diphenylpyrazine;4-(Isopropylamino)butanol;Brexpiprazole;7-hydroxyquinolin-2(1H)-one;7-(4-chlorobutoxy)-4a,8a-dihydroquinolin-2(1H)-one;4-bromobenzo[b]thiophene;1-(benzo[b]thiophen-4-yl)piperazine hydrochloride;Siponimod;Siponimed hemi-fumarate;(E)-4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzaldehyde;O-(4-cyclohexyl-3-(trifluoromethyl)benzyl)hydroxylamine;1-(3-ethyl-4-(hydroxymethyl)phenyl)ethan-1-one;Ozanimod;Ozanimod Hcl;(R)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate;1-oxo-2,3-dihydro-1H-indene-4-carbonitrile;Carbamic acid,N-[(1S)-2,3-dihydro-4-[(hydroxyamino);iminomethyl]-1H-inden-1-yl]-N-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-, 1,1-dimethylethyl ester;3-cyano-4-isopropoxybenzoic acid;Fingolimod;Fingolimod Hcl;N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide;N-[1,1-Bis[(acetyloxy)methyl]-3-phenylpropyl]acetamide;2-acetamido-2-(4-octanoylphenethyl)propane-1,3-diyl diacetate;2-acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate;Rimegepant;Rimegepant Sulfate;1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4-piperidinyl]-2H-imidazo[4,5-b]pyridin-2-one;7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione;(6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one;Darolutamide ;5-Acetyl-1H-Pyrazole-3-carboxylic acid;(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile;2-Chloro-4-(1H-pyazol-3-yl)benzonitrile;5-Acetyl-1(2)H-pyrazole-3-carboxylic acid ethyl ester;Erlotinib;Erlotinib Hcl;4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile;6,7-bis-(2-Methoxyethoxy)-quinazolin-4(3h)-one;Vibegron;5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide;tert-butyl (4-(3-(dimethoxyphosphoryl)-2-oxopropyl)phenyl)carbamate;tert-butyl (4S,5R)-4-formyl-2,2-dimethyl-5-phenyloxazolidine-3-carboxylate;tert-butyl (4R,5R)-4-((E)-4-(4-((tert-butoxycarbonyl)amino)phenyl)-3-oxobut-1-en-1-yl)-2,2-dimethyl-5-phenyloxazolidine-3-carboxylate;(R)-((2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol;Sodium (S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-;Crizotinib;1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester;(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine;Tert-butyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylate;Fezolinetant;(R)-3-methylpiperazin-2-one;3-methyl-1,2,4-thiadiazole-5-carbohydrazide;(R)-4-(2,4-diMethoxybenzyl)-3-Methylpiperazin-2-one;Elinzanetant;Pyrazino[2,1-c][1,4]oxazine, octahydro-7-[(phenylmethoxy)methyl]-, (7S,9aS)-, ethanedioate (1:2);N-[6-Chloro-4-(4-fluoro-2-methylp henyl)-3-pyridinyl]-N,a,a-trimethy;Vericiguat;5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide;2-(phenyldiazenyl)malononitrile;Diroximel Fumarate;1-(2-hydroxyethyl)pyrrolidine-2,5-dione;5-Hydroxy-7-azaindole;Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate;1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl) piperazine;3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide;Sorafenib tosylate;4-Chloro-N-Methylpyridine -2-Carboxamide;4-Chloro-3-(trifluoromethyl)phenyl isocyanate;4-(4-Aminophenoxy)-N-methylpicolinamide;Sunitinib malate;5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid;Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate;5-Fluoro-1,3-dihydro-2H-indol-2-one;Pazopanib HCL;2,3-dimethyl-2H-indazol-6-amine hydrochloride;3-Amino-6-methylbenzenesulfonamide;Axitinb;2-Mercapto-N-Methylbenzamide;6-Iodo-1H-indazole;Lenvatinib mesylate;1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarbonitrile;4-amino-3-chlorophenol;Tofacitinb;Tofacitinib citrate;(3R,4R)-1-Benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride;4-Chloropyrrolo[2,3-d]pyrimidine;(2,5-dioxopyrrolidin-1-yl) 2-cyanoacetate;Nintedanib;Nintedanib ethanesulfonate;N-(4-aminophenyl)-n,4-dimethyl-1-piperazineacetamide;Methyl 2-oxoindole-6-carboxylate;2-chloro-N-methyl-N-(4-nitrophenyl)acetamide;N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide;2-bromo-N-methyl-N-(4-nitrophenyl)acetamide;Methyl 4-(di(methoxycarbonyl)methyl)-3-nitrobenzoate;N-methyl-4-nitro-Benzenamine;Abiraterone acetate;Abiraterone;17-Iodoandrosta-5,16-dien-3β-ol;17-Iodoandrosta-5,16-dien-3β-acetate ester;879085-55-9;2-(2-chloro-5-nitrophenyl)pyridine;4-chloro-3-(pyridin-2-yl)aniline;Dantrolene Sodium;Olaparib;Acalabrutinib;Brigatinib;Crizotinib;Eltrombopag Olamine;Eltrombopag;Selexipag;Tofacitinib Citrate;Upadacitinib hemihydrate;Tasimelteon;Baricitinib;Dacomitinib;Lenvatinib mesylate;Erdafitinib;Pimobendan;Sulopenem Etzadroxil;Sulopenem;Lesinurad;Dabrafenib Mesylate;Dabrafenib;Capmatinib HCl hydrate;Ruxolitinib phosphate;Vandetanib;Darolutamide;Olaparib;Gefitinib;Erlotinib hydrochloride;Osimertinib mesylate;Siponimod;Siponimod fumarate;Fingolimod Hcl;Fingolimod;Tafamidis;Tafamidis Meglumine;Enzalutamide;VX-809;VX-661;VX-770;Rimegepant;Rimegepant Sulfate;Diroximel Fumarate;Danuglipron;Mitotane;Superoxide dismutase;Vibegron;Edaravone;Pirfenidone;Fezolinetant;N-(4-Oxocyclohexyl)acetamide;Trametinib;Trametinib DMSO solvate;Tepotinib Hydrochloride Hydrate;Cabozantinib Malate

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E12B15

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals